Profil
Deya Corzo worked as an Executive Director-Medical at Celgene Corp.
from 2012 to 2014.
She then worked as SVP-Research & Development, Head-Therapeutic Area at uniQure NV from 2014 to 2017.
From 2017 to 2018, she served as Chief Medical Officer at Sojournix, Inc. and from 2018 to 2021, she worked as Chief Medical Officer at Sigilon Therapeutics, Inc. Dr. Corzo holds a doctorate degree from Universidad Industrial de Santander.
Anciens postes connus de Deya Corzo
| Sociétés | Poste | Fin |
|---|---|---|
| SIGILON THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/08/2021 |
Sojournix, Inc.
Sojournix, Inc. BiotechnologyHealth Technology Operates in the healthcare industry focusing on biotechnology business | Directeur Technique/Scientifique/R&D | 01/01/2018 |
| UNIQURE N.V. | Directeur Technique/Scientifique/R&D | 01/01/2017 |
| CELGENE | Corporate Officer/Principal | 01/01/2014 |
Formation de Deya Corzo
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Universidad Industrial de Santander
Universidad Industrial de Santander Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
uniQure NV
uniQure NV BiotechnologyHealth Technology Engages in the discovery, development and commercialization of gene therapies products | Health Technology |
Sojournix, Inc.
Sojournix, Inc. BiotechnologyHealth Technology Operates in the healthcare industry focusing on biotechnology business | Health Technology |
Sigilon Therapeutics, Inc.
Sigilon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics and functional cures for patients with chronic diseases | Health Technology |
















